Table 1.
Clinical characteristics of quarantined patients
Total number of patients in quarantine in a hospital ward | 20 | |
---|---|---|
Median age (range) | 66 (21–76) | |
Male/female | 10/10 | |
Median BMI (range) | 25.05 (19.4–35) | |
Cancer diagnosis | ||
Gastrointestinal cancer | 8 (40%) | |
Lung cancer | 4 (20%) | |
Genitourinary cancer | 3 (15%) | |
Breast cancer | 2 (10%) | |
Gynaecological cancer | 2 (10%) | |
Head and neck cancer | 1 (5%) | |
Cancer stage/type of therapy | ||
Local/adjuvant | 9 (45%) | |
Metastatic/palliative | 11 (55%) | |
Concomitant diseases | 14 (70%) | |
Metabolic diseases (e.g. diabetes) | 6 (30%) | |
Cardiovascular system diseases (e.g. ischaemic heart disease, hypertension) | 6 (30%) | |
Other cancers in the past | 2 (10%) | |
Additional prophylactic therapy | ||
Heparin | 8 (40%) | |
G-CSF | 10 (50%) | |
COVID-19-infected patients | 11 (55%) | |
Symptoms and signs of COVID-19 infection | ||
Fever | 2 (10%) | |
Dyspnoea | 2 (10%) | |
Fatigue | 1 (5%) | |
Asymptomatic liver insufficiency | 1 (5%) |
BMI – body mass index, G-CSF – granulocyte colony-stimulating factor